Keywords: خال سرطانی یا ملانوما; Oxaliplatin; Cisplatin; Electrochemotherapy; Melanoma; Immunogenic cell death; Immune response;
مقالات ISI خال سرطانی یا ملانوما (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: خال سرطانی یا ملانوما; Melanoma; Biomarker; ctDNA; BRAF; Immunotherapy;
Keywords: خال سرطانی یا ملانوما; Phosphodiesterase Type 5 Inhibitors; Erectile Dysfunction; Safety; Melanoma; Prostate Cancer;
Keywords: خال سرطانی یا ملانوما; Melanoma; Genomic risk; Behavior change; Prevention; Cost-benefit analysis; Randomized controlled trial;
Keywords: خال سرطانی یا ملانوما; cost-effectiveness; decision modeling; economic evaluation; melanoma; screening;
Keywords: خال سرطانی یا ملانوما; Deep learning; Dermoscopy; Full resolution convolutional network (FrCN); Melanoma; Skin lesion segmentation;
Keywords: خال سرطانی یا ملانوما; choice-based conjoint analysis; delayed reconstruction; immediate reconstruction; immunostaining; incomplete excision; local recurrence wide local excision; margins of excision; melanoma; Mohs micrographic surgery; patient preference; positive margins; Sa
Keywords: خال سرطانی یا ملانوما; melanoma; National Cancer Database; stage I melanoma; survival; time to surgery; time to treatment; CoC; Commission on Cancer; LVI; lymphovascular invasion; MM; malignant melanoma; NCDB; National Cancer Database; OS; overall survival; SLNB; sentinel lymph
Keywords: خال سرطانی یا ملانوما; Melanoma; Computer vision; Machine learning; Ordinal classification; Partial order; Skin cancer;
Keywords: خال سرطانی یا ملانوما; Melanoma; Spitz tumor; Fluorescence in situ hybridization; Comparative genomic hybridization; Next-generation sequencing; Cell-free nucleic acid analysis; Programmed death receptor;
Keywords: خال سرطانی یا ملانوما; basal cell carcinoma; melanoma; military; nonmelanoma; occupational sun exposure; prevention; screening skin cancer; squamous cell carcinoma; veterans; OEF; Operation Enduring Freedom; OIF; Operation Iraqi Freedom; USAF; United States Air Force; UV; ultra
Keywords: خال سرطانی یا ملانوما; UVB; UVA; Melanoma; MC1R; NER; Immunosuppression;
Keywords: خال سرطانی یا ملانوما; Bioinformatics; Melanoma; nLC-MS/MS; Proteomics; Radiation; UV; WM-266-4;
Keywords: خال سرطانی یا ملانوما; Brain metastases; Breast cancer; Lung cancer; Melanoma; Whole brain radiation; Stereotactic radiosurgery;
Keywords: خال سرطانی یا ملانوما; crystalline/chrysalis structures; dermoscopy; histology; melanoma; nevi; pigmented skin lesions; polarized dermoscopy; shiny white streaks; MIS; melanoma in situ; NPV; negative predictive value; PPV; positive predictive value; SWS; shiny white streak;
Keywords: خال سرطانی یا ملانوما; Ultrasound; PLGA microspheres; Doxorubicin; Melanoma; Controlled drug release; Inertial cavitation; Cancer therapy;
Keywords: خال سرطانی یا ملانوما; Lymph node dissection; Skin flap; Tumor growh; Melanoma; Adaptive immunity;
Keywords: خال سرطانی یا ملانوما; ARID; Age Related Immune Differences; CD40L; CD40 ligand; CTLA-4; cytotoxic T lymphocyte antigen-4; IL; interleukin; Lag3; lymphocyte activation gene 3; MDSC; myeloid derived suppressor cell; MHC; major histocompatibility complex; mTOR; mammalian target o
Keywords: خال سرطانی یا ملانوما; GR; glutathione reductase; ROS; reactive oxygen species; 2-AAPA; 2-Acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylcarbonylamino) phenyl carbamoylsulfanyl] propionic acid; EMT; epithelial-to-mesenchymal transition; FBS; fetal bovine serum; PBS; phos
Keywords: خال سرطانی یا ملانوما; DSC; Differential Scanning Calorimetry; CT; Computed Tomography; GAC; Gastric Adenocarcinoma; IRB; Institutional Review Board; MUSP; Melanoma Under Surveillance Patients; MC; Melanoma Controls; NED; No Evidence of Disease; Cp; Heat Capacity; T; Temperatur
Keywords: خال سرطانی یا ملانوما; Circulating tumor cells; Biomarker; Melanoma; Cancer; Liquid biopsy;
Keywords: خال سرطانی یا ملانوما; Melanoma; Feature extraction; Lesion peripheral information; Daugman rubber sheet model;
Keywords: خال سرطانی یا ملانوما; Acquisition; Classification; Dermoscopy; Melanoma; Pigmented skin lesions (PSLs); Segmentation;
Keywords: خال سرطانی یا ملانوما; Breslow thickness; melanoma; misclassification; precision; T category; terminal digit clustering; AJCC; American Joint Committee of Cancer; ALM; acral lentiginous melanoma; CM; cutaneous melanoma; CRN; Cancer Registry of Norway; NM; nodular melanoma; NMMR
Keywords: خال سرطانی یا ملانوما; Core-shell nanofiber; Melanoma; Electrospinning; Controlled drug release;
Keywords: خال سرطانی یا ملانوما; biopsy; cost; detection; melanoma; screening; skin cancer; CI; confidence interval; EMR; electronic medical record; ICD; International Classification of Diseases; NMSC; nonmelanoma skin cancer; NNB; number needed to biopsy; NNS; number needed to screen;
Keywords: خال سرطانی یا ملانوما; Hospice; melanoma; end of life;
Keywords: خال سرطانی یا ملانوما; clinical research; guidelines; melanoma; mitotic rate; skin cancer; staging; AJCC; American Joint Commission on Cancer; CI; confidence interval; NCDB; National Cancer Database; OR; odds ratio; SLNB; sentinel lymph node biopsy;
Keywords: خال سرطانی یا ملانوما; Melanoma; Adjuvant treatment; Nivolumab; Pembrolizumab; Target therapy; New strategies;
Keywords: خال سرطانی یا ملانوما; aspirin; melanoma; platelets; stage; survival; treatment; CPH; Cox proportional hazards; CI; confidence interval; HR; hazard ratio; TGFβ; transforming growth factor-β;
Keywords: خال سرطانی یا ملانوما; Adenosine; Adenosine receptors; Melanoma;
Keywords: خال سرطانی یا ملانوما; dermatopathology; diagnosis; discordance; melanocytic lesions; melanoma; observer variability; pathologist characteristics; CI; confidence interval; MPATH-Dx; Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis; OR; odds ratio;
Keywords: خال سرطانی یا ملانوما; ASIP; Agouti signalling protein; BMDC; bone marrow-derived cell; ERK; extracellular signal-regulated kinase; GPCR; G protein-coupled receptor; HBD3; human β-defensin 3; KITLG; KIT ligand; LN; lymph node; MC; melanoma cell; MC1R; melanocortin 1 receptor;
Keywords: خال سرطانی یا ملانوما; Melanoma; Nanoparticles; Targeted drug delivery;
Keywords: خال سرطانی یا ملانوما; melanocytic hyperplasia; melanoma; melanonychia; nail; pediatric; subungual; ALMP; atypical lentiginous melanocytic proliferation; FISH; fluorescence in situ hybridization; MIS; melanoma in situ;
Keywords: خال سرطانی یا ملانوما; ICI; immune checkpoint inhibition; irAE; immune related adverse event; TME; tumor microenvironment; Melanoma; Biomarker; Checkpoint inhibitor; PD-1; CTLA-4;
Keywords: خال سرطانی یا ملانوما; Phenotype switching; Melanoma; Cancer-associated fibroblasts; Drug resistance; Tumor-stroma interactions; CAF; Cancer associated fibroblasts; CDSS; Cancer drug sensitivity screening; EMT; Epithelial-to-mesenchymal transition; FACS; Fluorescence-activated
Keywords: خال سرطانی یا ملانوما; Melanoma; Autophagy; Chemosensitization; Cisplatin; Nutrient deprivation; Starvation;
Keywords: خال سرطانی یا ملانوما; Vemurafenib; Melanoma; Liposome; Peptide; Transdermal delivery;
Keywords: خال سرطانی یا ملانوما; Cinnamic acid; 1,2,3-triazoles; Antimetastatic; Melanoma; Click chemistry; Gelatinases; Matrix metalloproteinase; Virtual molecular docking;
Keywords: خال سرطانی یا ملانوما; Melanoma; Nevi; Melanocytic; Immunohistochemistry; Genetics; Diagnosis;
Keywords: خال سرطانی یا ملانوما; Fentanyl; Cancer pain; Mu-opioid receptor; Naloxone; Melanoma;
Keywords: خال سرطانی یا ملانوما; CV; coefficient of variation; DDA; data dependent acquisition; GC; gas chromatography; HS SPME; headspace solid phase micro extraction method; IDO; indoleamine 2,3-dixygenase; LC; liquid chromatography; PLS-DA; partial least squares discriminant analysis;
Keywords: خال سرطانی یا ملانوما; Extracellular vesicles; Glycosylation; Lectins; Melanoma; N-glycans;
Keywords: خال سرطانی یا ملانوما; Structural co-occurrence matrix; Image classification; Melanoma; Machine learning;
Keywords: خال سرطانی یا ملانوما; Melanoma; Clotrimazole; Glycyl-glycine; Amphiphilic; Self assembled nanomicelles; Cytotoxicity; Apoptosis; Tumour suppression; Antioxidant;
Keywords: خال سرطانی یا ملانوما; Photodynamic therapy; Melanoma; Chlorins; Photosensitizer; Photophysics;
Keywords: خال سرطانی یا ملانوما; Therapeutic cancer vaccine; Layered double hydroxides; Colloidal stability; Personalized immunotherapy; Melanoma;
Keywords: خال سرطانی یا ملانوما; Melanoma; Metastasis; Brain; BRAF; Immunotherapy;
Keywords: خال سرطانی یا ملانوما; Photodynamic therapy; Singlet oxygen; Melanoma; Targeting; Nanoparticles;